Clinical Trial Update: A Retreatment Study With Bortezomib for Multiple Myeloma

View source ↗

Summary

This clinical trial update reports a retreatment study of bortezomib for multiple myeloma, which has now been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Multiple Myeloma | Status: COMPLETED